← Back to Search

Protein Supplement for Lower Back Pain

N/A
Waitlist Available
Research Sponsored by Kamshad Raiszadeh, MD
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 3 months, 6 months, 1 year, 2 years
Awards & highlights

Study Summary

This trial is testing whether a new physical therapy program, that uses technology and focuses on the cervical, thoracic, and lumbar spine, is effective. The therapy includes exercises and patient education on healthy lifestyle choices. The trial will also test whether providing patients with access to nutritional supplements helps the therapy be more effective.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~3 months, 6 months, 1 year, 2 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and 3 months, 6 months, 1 year, 2 years for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Muscle size
Secondary outcome measures
Change in disability
Change in strength (lbs*deg)
Patient Goal Achievement
+1 more

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Protein Intervention GroupExperimental Treatment1 Intervention
Patients who receive the protein nutritional supplement as part of their prescribed exercise-based rehabilitation program.
Group II: Control GroupActive Control1 Intervention
Patients who receive the prescribed exercise-based rehabilitation program, without protein supplement.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Protein supplement
2013
N/A
~160

Find a Location

Who is running the clinical trial?

University of California, San DiegoOTHER
1,126 Previous Clinical Trials
1,552,891 Total Patients Enrolled
Kamshad Raiszadeh, MDLead Sponsor
Bahar Shahidi, PT, PhDStudy DirectorUCSD Orthopedic Surgery

Media Library

Protein supplement Clinical Trial Eligibility Overview. Trial Name: NCT04829448 — N/A
Lower Back Pain Research Study Groups: Protein Intervention Group, Control Group
Lower Back Pain Clinical Trial 2023: Protein supplement Highlights & Side Effects. Trial Name: NCT04829448 — N/A
Protein supplement 2023 Treatment Timeline for Medical Study. Trial Name: NCT04829448 — N/A
Lower Back Pain Patient Testimony for trial: Trial Name: NCT04829448 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Who is eligible to take part in this experiment?

"In order to partake in this trial, potential patients must have low back pain and be between 18-89 years old. 100 volunteers are needed for the experiment."

Answered by AI

Is participation in this research study still available at the present time?

"As perclinicaltrials.gov, this clinical trial has ceased its recruitment efforts after being posted on March 16th 2022 and not receiving updates since then. Despite that, there are still 286 other medical studies searching for volunteers at present."

Answered by AI

Do those over the age of sixty have access to this clinical exploration?

"The stated eligibility parameters of this trial set the minimum age for participation at 18 and the maximum allowable age is 89."

Answered by AI

Who else is applying?

What state do they live in?
California
How old are they?
18 - 65
What site did they apply to?
SpineZone
What portion of applicants met pre-screening criteria?
Did not meet criteria
Met criteria
How many prior treatments have patients received?
0
3+

Why did patients apply to this trial?

Looking to prevent injuries and making money. Had a X-ray that showed mild degenerative disease of the lumbar and cervical spine. I work out, stretch, take ibuprofen, heat, stim and still an issue more days than not.
PatientReceived 1 prior treatment
~46 spots leftby Apr 2026